359 related articles for article (PubMed ID: 32914012)
1. Precision Oncology in Sarcomas: Divide and Conquer.
Carmagnani Pestana R; Groisberg R; Roszik J; Subbiah V
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914012
[TBL] [Abstract][Full Text] [Related]
2. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience.
Cote GM; He J; Choy E
Oncologist; 2018 Feb; 23(2):234-242. PubMed ID: 28860410
[TBL] [Abstract][Full Text] [Related]
5. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
6. Novel Aspects of Genetics, Molecular Biology and Clinical Oncology of Sarcomas.
Houfková K; Hatina J
Klin Onkol; 2020; 33(1):66-78. PubMed ID: 32075391
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
8. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
Zhu MMT; Shenasa E; Nielsen TO
Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy for sarcomas.
Forscher C; Mita M; Figlin R
Biologics; 2014; 8():91-105. PubMed ID: 24669185
[TBL] [Abstract][Full Text] [Related]
10. More Than 50 Subtypes of Soft Tissue Sarcoma: Paving the Path for Histology-Driven Treatments.
Katz D; Palmerini E; Pollack SM
Am Soc Clin Oncol Educ Book; 2018 May; 38():925-938. PubMed ID: 30231352
[TBL] [Abstract][Full Text] [Related]
11. Addressing Modern Diagnostic Pathology for Patient-Derived Soft Tissue Sarcosphere Models in the Era of Functional Precision Oncology.
Chen Y; Herzog M; Pliego-Mendieta A; Bühler MM; Harnisch KJ; Haberecker M; Arnold F; Planas-Paz L; Pauli C
Lab Invest; 2023 Apr; 103(4):100039. PubMed ID: 36870294
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification of soft tissue sarcomas and its clinical applications.
Jain S; Xu R; Prieto VG; Lee P
Int J Clin Exp Pathol; 2010 Apr; 3(4):416-28. PubMed ID: 20490332
[TBL] [Abstract][Full Text] [Related]
13. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
14. Managing sarcoma: where have we come from and where are we going?
Bleloch JS; Ballim RD; Kimani S; Parkes J; Panieri E; Willmer T; Prince S
Ther Adv Med Oncol; 2017 Oct; 9(10):637-659. PubMed ID: 28974986
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
16. A review of soft-tissue sarcomas: translation of biological advances into treatment measures.
Hoang NT; Acevedo LA; Mann MJ; Tolani B
Cancer Manag Res; 2018; 10():1089-1114. PubMed ID: 29785138
[TBL] [Abstract][Full Text] [Related]
17. Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications.
Xiao X; Garbutt CC; Hornicek F; Guo Z; Duan Z
Cancer Treat Rev; 2018 Feb; 63():61-70. PubMed ID: 29247978
[TBL] [Abstract][Full Text] [Related]
18. Case report: The activity of multi-kinase VEGF inhibitor, Pazopanib, in metastatic undifferentiated round cell sarcomas harboring
Campoverde L; Camacho F; Alessandrino F; Evans MG; Elliot A; Rosenberg A; Trent J
Front Oncol; 2023; 13():1215003. PubMed ID: 37829338
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
Italiano A; Dinart D; Soubeyran I; Bellera C; Espérou H; Delmas C; Mercier N; Albert S; Poignie L; Boland A; Bourdon A; Geneste D; Cavaille Q; Laizet Y; Khalifa E; Auzanneau C; Squiban B; Truffaux N; Olaso R; Gerber Z; Wallet C; Bénard A; Blay JY; Laurent-Puig P; Deleuze JF; Lucchesi C; Mathoulin-Pelissier S;
BMC Cancer; 2021 Nov; 21(1):1180. PubMed ID: 34740331
[TBL] [Abstract][Full Text] [Related]
20. Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors.
Fontebasso AM; Rytlewski JD; Blay JY; Gladdy RA; Wilky BA
Surg Oncol Clin N Am; 2024 Apr; 33(2):387-408. PubMed ID: 38401916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]